By Peter A. McCullough, MD, MPH
In clinical medicine there are always many ways to successfully treat patients. That is why no two doctors agree on the same exact treatment plan. The SARS-CoV-2 outbreak and COVID-19 pandemic called for innovation working around government imposed constraints.
Watch this exclusive interview with internist Sean Downing, MD, on his rationale for a triple combination of medications that addressed a key part of COVID-19 illness, that is, multisystem inflammation. Here is an excerpt from his manuscript:
Click this link for the original source of this article.
Author: Peter A. McCullough, MD, MPH
This content is courtesy of, and owned and copyrighted by, https://petermcculloughmd.substack.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.